Proxy Votes Now

Home › Funds › Brighthouse › Brighthouse/Wellington Large Cap Research Portfolio

Brighthouse/Wellington Large Cap Research Portfolio proxy voting record 2025-2026

Fund family: Brighthouse · Filed by Brighthouse Funds Trust I (CIK 1126087) · SEC series S000011125

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,022 with, 131 against, 4 abstentions (not counted as with management); 6 items carried no recommendation. Shareholder proposals: 34 FOR, 98 AGAINST, 2 abstained, by the filing’s own vote-source field.

Compared with Brighthouse as a whole

The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBrighthouseItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.0%1,94576.3%204,500
Backed environmental and social shareholder proposals at US companies9.5%7412.8%1,182

Where this fund voted differently from most Brighthouse funds

Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Brighthouse funds on 481 items (28.8% of the 1,671 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
The Goldman Sachs Group, Inc.2026-04-29Shareholder Shareholder Proposal Regarding Disclosure of Energy Supply RatioForABSTAIN or AGAINST — 13 of 15 Brighthouse fundsAgainstNot approved, 18.4% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Shona L. BrownForAGAINST or ABSTAIN — 10 of 11 Brighthouse fundsForElected, 89.8% support
Vertiv Holdings Co2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Joseph van DokkumForWITHHOLD — 10 of 11 Brighthouse fundsForPassed (calculated), 54.2% support
Amgen Inc.2026-05-19Shareholder Stockholder proposal to require an independent board chairman.ForABSTAIN or AGAINST — 12 of 14 Brighthouse fundsAgainstNot approved, 17.7% support
NetApp, Inc.2025-09-10To approve an amendment to NetApp's 2021 Equity Incentive Plan.ForAGAINST or ABSTAIN — 9 of 10 Brighthouse fundsForApproved, 68.0% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Joseph L. Goldstein, M.D.ForABSTAIN or AGAINST — 11 of 13 Brighthouse fundsForElected, 70.1% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Energy Supply Ratio.ForABSTAIN or AGAINST — 13 of 16 Brighthouse fundsAgainstFailed (calculated), 20.6% support
Broadcom Inc.2026-04-20Advisory vote to approve the named executive officer compensation.ForAGAINST or ABSTAIN — 14 of 18 Brighthouse fundsForApproved, 66.4% support
Berkshire Hathaway Inc.2026-05-02Elect Charlotte GuymanForWITHHOLD — 7 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Susan L. DeckerForWITHHOLD — 7 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Charles BakerForABSTAIN or AGAINST — 7 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Teresa A. TaylorForWITHHOLD — 7 of 8 Brighthouse fundsFor—
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to establish stockholders' meetings as the sole mechanism for approval of matters on which holders of common stock are required or permitted to vote.ForAGAINST or ABSTAIN — 7 of 8 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Shareholder A shareholder proposal regarding report on AI data usage oversight.ForABSTAIN or AGAINST — 11 of 14 Brighthouse fundsAgainst—
Meta Platforms, Inc.2026-05-27Elect Andrew W. HoustonForWITHHOLD — 10 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect Mark ZuckerbergForWITHHOLD — 10 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect Nancy KilleferForWITHHOLD — 10 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect Tony XuForWITHHOLD — 10 of 13 Brighthouse fundsFor—
Palantir Technologies Inc.2026-06-03Advisory vote to approve named executive officer compensation.ForABSTAIN or AGAINST — 10 of 13 Brighthouse fundsForApproved, 84.8% support
Arista Networks, Inc.2026-05-29Approval, on an advisory basis, of the compensation of our named executive officers.ForABSTAIN or AGAINST — 10 of 13 Brighthouse fundsForApproved, 60.4% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Christine A. PoonForABSTAIN or AGAINST — 10 of 13 Brighthouse fundsForElected, 76.8% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Craig B. Thompson, M.D.ForABSTAIN or AGAINST — 10 of 13 Brighthouse fundsForElected, 79.3% support
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Ambassador Susan RiceForABSTAIN — 8 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Jay HoagForABSTAIN or AGAINST — 8 of 10 Brighthouse fundsFor—
Medtronic plc2025-10-16Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2026 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remunerationForABSTAIN or AGAINST — 6 of 7 Brighthouse fundsFor—
Show all 481
Items 26 to 481.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Marvell Technology, Inc.2026-06-25An advisory (non-binding) vote to approve compensation of our named executive officers.ForABSTAIN or AGAINST — 6 of 7 Brighthouse fundsForApproved, 55.9% support
HCA Healthcare, Inc.2026-04-23Advisory vote to approve named executive officer compensationForABSTAIN or AGAINST — 6 of 7 Brighthouse fundsFor—
Exxon Mobil Corporation2026-05-27Shareholder Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000ForAGAINST or ABSTAIN — 11 of 15 Brighthouse fundsAgainstFailed (calculated), 15.2% support
Exxon Mobil Corporation2026-05-27Texas RedomiciliationForAGAINST or ABSTAIN — 11 of 15 Brighthouse fundsForPassed (calculated), 71.2% support
The Goldman Sachs Group, Inc.2026-04-29Advisory Vote to Approve Executive Compensation (Say on Pay)ForAGAINST or ABSTAIN — 11 of 15 Brighthouse fundsForApproved, 70.6% support
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Sue WagnerForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Aarti ShahForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Stephen C. NealForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Frances H. ArnoldForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Ratification of appointment of Ernst & Young LLP as Alphabet's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Shareholder Shareholder proposal to provide for an independent Board chair.ForABSTAIN or AGAINST — 9 of 12 Brighthouse fundsAgainstNot approved, 21.0% support
Tesla, Inc.2025-11-06A Tesla proposal to elect Class III Director to serve for a term of three years, or until their respective successors are duly elected and qualified: Kathleen Wilson-ThompsonForABSTAIN or AGAINST — 7 of 9 Brighthouse fundsFor—
Advanced Micro Devices, Inc.2026-05-13Approve on a non-binding advisory basis the compensation of the named executive officers, as disclosed in the proxy statement pursuant to the compensation disclosure rules of the U.S. Securities and Exchange Commission.ForABSTAIN or AGAINST — 7 of 9 Brighthouse fundsFor—
The Goldman Sachs Group, Inc.2026-04-29Election of Directors: Kimberley HarrisForABSTAIN or AGAINST — 10 of 14 Brighthouse fundsForElected, 73.9% support
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Brian J. DrukerForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Mary E. KlotmanForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Michael V. DrakeForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. S. Omar IshrakForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Tyler JacksForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Dr. Wanda M. AustinForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Charles M. Holley, Jr.ForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Greg C. GarlandForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. BradwayForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Mr. Robert A. EckertForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Amy E. MilesForABSTAIN — 7 of 9 Brighthouse fundsFor—
Amgen Inc.2026-05-19Election of Directors for a term of office expiring at the 2027 annual meeting of stockholders: Ms. Ellen J. KullmanForABSTAIN — 7 of 9 Brighthouse fundsFor—
Vertex Pharmaceuticals Incorporated2026-05-13Election of Directors: Lloyd A. CarneyForABSTAIN or AGAINST — 7 of 9 Brighthouse fundsFor—
Natera, Inc.2026-06-11Elect Eric H. RubinForWITHHOLD — 7 of 9 Brighthouse fundsFor—
Natera, Inc.2026-06-11Elect Herm RosenmanForWITHHOLD — 7 of 9 Brighthouse fundsFor—
Natera, Inc.2026-06-11Elect Jonathan SheenaForWITHHOLD — 7 of 9 Brighthouse fundsFor—
Natera, Inc.2026-06-11Elect Rowan ChapmanForWITHHOLD — 7 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Jessica L. DenecourForABSTAIN or AGAINST — 7 of 9 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Dorothy C. ThompsonForABSTAIN or AGAINST — 5 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Kelt KindickForWITHHOLD — 5 of 6 Brighthouse fundsFor—
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Alfred LinForABSTAIN or AGAINST — 8 of 11 Brighthouse fundsForElected, 93.8% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Stanley TangForABSTAIN or AGAINST — 8 of 11 Brighthouse fundsForElected, 94.0% support
Meta Platforms, Inc.2026-05-27Elect Charles SonghurstForWITHHOLD — 9 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect John ArnoldForWITHHOLD — 9 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect Patrick CollisonForWITHHOLD — 9 of 13 Brighthouse fundsFor—
Meta Platforms, Inc.2026-05-27Elect Robert M. KimmittForWITHHOLD — 9 of 13 Brighthouse fundsFor—
Tesla, Inc.2025-11-06A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation.ForABSTAIN or AGAINST — 10 of 15 Brighthouse fundsForApproved, 78.7% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.ForABSTAIN or AGAINST — 10 of 15 Brighthouse fundsForApproved, 79.1% support
PepsiCo, Inc.2026-05-06Shareholder Shareholder Proposal - Independent Board Chair.ForAGAINST or ABSTAIN — 9 of 13 Brighthouse fundsAgainstNot approved, 25.8% support
Berkshire Hathaway Inc.2026-05-02Elect Ajit JainForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Christopher C. DavisForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Gregory E. AbelForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Howard G. BuffettForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Kenneth I. ChenaultForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Meryl B. WitmerForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Stephen B. BurkeForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Susan A. BuffettForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Thomas S. Murphy, Jr.ForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Wallace R. WeitzForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Elect Warren E. BuffettForWITHHOLD — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. F. William McNabb IIIForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. John Noseworthy, M.D.ForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Kristen GilForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Paul GarciaForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Scott Gottlieb, M.D.ForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Stephen HemsleyForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Timothy FlynnForABSTAIN — 6 of 8 Brighthouse fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Valerie Montgomery Rice, M.D.ForABSTAIN — 6 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Bruce R. ChizenForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Welltower Inc.2026-05-21The approval, on an advisory basis, of the compensation of the named executive officers.ForAGAINST or ABSTAIN — 6 of 8 Brighthouse fundsForNot approved, 18.9% support
T-Mobile US, Inc.2026-06-16Elect Christian P. IllekForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Dominique LeroyForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect James J. KavanaughForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Letitia A. LongForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Marcelo ClaureForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Mike SievertForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Raphael KublerForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Srikant M. DatarForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Srinivasan GopalanForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Thomas DannenfeldtForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Thorsten LangheimForWITHHOLD — 6 of 8 Brighthouse fundsFor—
T-Mobile US, Inc.2026-06-16Elect Timotheus HottgesForWITHHOLD — 6 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Marianne C. BrownForABSTAIN or AGAINST — 6 of 8 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Approve, on an advisory basis, the compensation of our executive officers.ForABSTAIN or AGAINST — 6 of 8 Brighthouse fundsForApproved, 72.1% support
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Ann MatherForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Anne SweeneyForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Brad SmithForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Elinor MertzForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Greg PetersForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Leslie KilgoreForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Strive MasiyiwaForABSTAIN — 7 of 10 Brighthouse fundsFor—
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders. Ted SarandosForABSTAIN — 7 of 10 Brighthouse fundsFor—
Datadog, Inc.2026-06-15To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Dev IttycheriaForWITHHOLD — 7 of 10 Brighthouse fundsForElected, 88.8% support
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Alex GorskyForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Andrea JungForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Art LevinsonForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Monica LozanoForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Ron SugarForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Tim CookForABSTAIN — 8 of 12 Brighthouse fundsFor—
Apple Inc.2026-02-24The election to Apple's Board of Directors of the eight nominees named in the Proxy Statement Nominees: Wanda AustinForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. A. Brooke SeawellForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Dawn HudsonForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Harvey C. JonesForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Jen-Hsun HuangForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. John O. DabiriForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Mark A. StevensForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Melissa B. LoraForABSTAIN — 8 of 12 Brighthouse fundsFor—
NVIDIA Corporation2026-06-24Election of Directors. Tench CoxeForABSTAIN — 8 of 12 Brighthouse fundsFor—
Microsoft Corporation2025-12-05Election of Directors Sandra E. PetersonForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock.ForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: K. Ram ShriramForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: L. John DoerrForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Larry PageForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: R. Martin Marty ChavezForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Robin L. WashingtonForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Roger W. Ferguson Jr.ForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Sergey BrinForABSTAIN — 8 of 12 Brighthouse fundsFor—
Alphabet Inc.2026-06-05Election of Directors: Sundar PichaiForABSTAIN — 8 of 12 Brighthouse fundsFor—
Advanced Micro Devices, Inc.2026-05-13Shareholder Stockholder proposal requesting changes to the stockholder right to call a special meeting.ForABSTAIN or AGAINST — 9 of 14 Brighthouse fundsAgainstNot approved, 37.5% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair.ForABSTAIN or AGAINST — 10 of 16 Brighthouse fundsAgainstFailed (calculated), 34.3% support
Wells Fargo & Company2026-04-28Advisory resolution to approve executive compensation (Say on Pay).ForABSTAIN or AGAINST — 10 of 16 Brighthouse fundsForPassed (calculated), 65.9% support
Vertex Pharmaceuticals Incorporated2026-05-13Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.ForABSTAIN or AGAINST — 9 of 14 Brighthouse fundsAgainstApproved, 57.0% support
Nucor Corporation2026-05-14Elect Christopher J. KearneyForWITHHOLD — 4 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Ratification of the appointment of PricewaterhouseCoopers LLP to serve as Nucor's independent registered public accounting firm for 2026.ForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Advisory vote on the ratification of independent auditors.ForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Mark A. SchulzForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
Coherent Corp.2025-11-13Election of Director for a three-year term to expire at the annual meeting of shareholders in 2028: Lisa Neal-GravesForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
Atmos Energy Corporation2026-02-04Proposal for an advisory vote by shareholders to approve the compensation of the Company's named executive officers for fiscal 2025 (Say-on-Pay).ForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Christy JacobyForABSTAIN or AGAINST — 4 of 5 Brighthouse fundsFor—
Tesla, Inc.2025-11-06Shareholder A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting.ForABSTAIN or AGAINST — 9 of 15 Brighthouse fundsAgainstNot approved, 32.3% support
Tesla, Inc.2025-11-06Shareholder A shareholder proposal to seek shareholder approval before adopting an amendment to the bylaws pursuant to Section 21.373 of the TBOC.ForABSTAIN or AGAINST — 9 of 15 Brighthouse fundsAgainstNot approved, 49.4% support
Walmart Inc.2026-06-04Approval of an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers as permitted by Delaware lawForABSTAIN or AGAINST — 10 of 17 Brighthouse fundsForPassed (calculated), 94.3% support
Arista Networks, Inc.2026-05-29Elect Greg LavenderForWITHHOLD — 5 of 7 Brighthouse fundsFor—
Arista Networks, Inc.2026-05-29Elect Lewis ChewForWITHHOLD — 5 of 7 Brighthouse fundsFor—
Arista Networks, Inc.2026-05-29Elect Mark B. TempletonForWITHHOLD — 5 of 7 Brighthouse fundsFor—
Medtronic plc2025-10-16Approving an amendment to Article 17 of the Company's Articles of Association, to facilitate the capitalization of certain of the Company's non-distributable reservesForABSTAIN — 5 of 7 Brighthouse fundsFor—
Medtronic plc2025-10-16Approving, on an advisory basis, the Company's executive compensationForABSTAIN — 5 of 7 Brighthouse fundsFor—
Medtronic plc2025-10-16Renewing the Board of Directors' authority to issue shares under Irish lawForAGAINST — 5 of 7 Brighthouse fundsFor—
Medtronic plc2025-10-16Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish lawForAGAINST — 5 of 7 Brighthouse fundsFor—
Marsh & McLennan Companies, Inc.2026-05-21Advisory (Nonbinding) vote to approve named executive officer compensation.ForABSTAIN or AGAINST — 5 of 7 Brighthouse fundsFor—
Marsh & McLennan Companies, Inc.2026-05-21Ratification of selection of independent registered public accounting firm.ForABSTAIN or AGAINST — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Shareholder To vote on a stockholder proposal regarding stockholders' right to act by written consent, if properly presented at the meeting.ForABSTAIN — 5 of 7 Brighthouse fundsAgainst—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Bruce R. ChizenForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Dr. Aart J. de GeusForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Janice D. ChaffinForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Jeannine P. SargentForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. John G. SchwarzForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Mercedes JohnsonForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Peter A. ShimerForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Ravi VijayaraghavanForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Robert G. PainterForABSTAIN — 5 of 7 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16Election of directors nominated by our Board of Directors to hold office until the next annual meeting of stockholders or until their successors have been elected. Sassine GhaziForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Alan J. MurrayForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Bill BrundageForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Brian MayForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Catherine A. HalliganForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Geoff DrabbleForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: James S. MetcalfForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Kelly BakerForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Kevin MurphyForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Rekha AgrawalForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Rick BeckwittForABSTAIN — 5 of 7 Brighthouse fundsFor—
Ferguson Enterprises Inc.2025-12-03To elect each of the 11 Director nominees named in the Proxy Statement to hold office until the Company's next annual meeting of stockholders and until such Director's successor shall have been elected and qualified: Suzanne H. WoodForABSTAIN — 5 of 7 Brighthouse fundsFor—
Palantir Technologies Inc.2026-06-03Elect Alexander C. KarpForWITHHOLD — 6 of 9 Brighthouse fundsFor—
Palantir Technologies Inc.2026-06-03Elect Eric WoerschingForWITHHOLD — 6 of 9 Brighthouse fundsFor—
Palantir Technologies Inc.2026-06-03Elect Lauren Friedman StatForWITHHOLD — 6 of 9 Brighthouse fundsFor—
Palantir Technologies Inc.2026-06-03Elect Stephen CohenForWITHHOLD — 6 of 9 Brighthouse fundsFor—
Vertex Pharmaceuticals Incorporated2026-05-13Election of Directors: Suketu UpadhyayForABSTAIN — 6 of 9 Brighthouse fundsFor—
Vertiv Holdings Co2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Joseph J. DeAngeloForWITHHOLD — 7 of 11 Brighthouse fundsForPassed (calculated), 74.9% support
Vertiv Holdings Co2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Roger FradinForWITHHOLD — 7 of 11 Brighthouse fundsForPassed (calculated), 70.3% support
Vertiv Holdings Co2026-06-17Elect each of the following eleven director nominees to our Board of Directors, each for a term of one year expiring at the 2027 annual meeting of stockholders and until such director's successor has been duly elected and qualified: Steven S. ReinemundForWITHHOLD — 7 of 11 Brighthouse fundsForPassed (calculated), 76.6% support
American International Group, Inc.2026-05-13Election of Directors: Diana M. MurphyAgainstFOR — 6 of 9 Brighthouse fundsAgainstElected, 91.2% support
American International Group, Inc.2026-05-13Election of Directors: Juan R. PerezAgainstFOR — 6 of 9 Brighthouse fundsAgainstElected, 91.9% support
American International Group, Inc.2026-05-13Election of Directors: Linda A. MillsAgainstFOR — 6 of 9 Brighthouse fundsAgainstElected, 88.9% support
PG&E Corporation2026-05-21Election of Director: Arno L. HarrisForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Benjamin F. WilsonForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Carlos M. HernandezForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Cheryl F. CampbellForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Edward G. CannizzaroForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: John O. LarsenForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Kerry W. CooperForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Leo P. DenaultForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Mark E. Ferguson IIIForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Patricia K. PoppeForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: Rajat BahriForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: W. Craig FugateForABSTAIN — 6 of 9 Brighthouse fundsFor—
PG&E Corporation2026-05-21Election of Director: William L. SmithForABSTAIN — 6 of 9 Brighthouse fundsFor—
MKS Inc.2026-05-11The approval, on an advisory basis, of a Company proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 25%.AbstainFOR — 6 of 9 Brighthouse fundsAgainstPassed (calculated), 98.5% support
Oracle Corporation2025-11-18Advisory Vote to Approve the Compensation of our Named Executive OfficersForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForPassed (calculated), 81.9% support
The Goldman Sachs Group, Inc.2026-04-29Election of Directors: John HessAgainstFOR — 8 of 14 Brighthouse fundsAgainstElected, 96.4% support
Amgen Inc.2026-05-19To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2026.ForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForApproved, 94.1% support
Intuit Inc.2026-01-22Advisory vote to approve Intuit's executive compensation (say-on-pay)ForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForPassed (calculated), 93.2% support
Regeneron Pharmaceuticals, Inc.2026-06-12Proposal to approve, on an advisory basis, compensation of the Named Executive Officers.ForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForApproved, 93.3% support
Regeneron Pharmaceuticals, Inc.2026-06-12Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN or AGAINST — 8 of 14 Brighthouse fundsForApproved, 94.1% support
Natera, Inc.2026-06-11To approve an amendment to Natera's 2015 Equity Incentive Plan, as amended and restated.ForABSTAIN or AGAINST — 9 of 16 Brighthouse fundsForPassed (calculated), 78.1% support
Microsoft Corporation2025-12-05Election of Directors: Hugh F. JohnstonAgainstFOR — 11 of 21 Brighthouse fundsAgainstPassed (calculated), 91.5% support
Netflix, Inc.2026-06-04To elect twelve directors to hold office until the 2027 Annual Meeting of Stockholders: Mathias DopfnerForABSTAIN — 7 of 12 Brighthouse fundsForElected, 97.2% support
The Boeing Company2026-04-17Shareholder Action by Written Consent.AgainstFOR — 10 of 19 Brighthouse fundsForFailed (calculated), 39.7% support
Broadcom Inc.2026-04-20Election of Directors: Henry S. SamueliForABSTAIN — 6 of 10 Brighthouse fundsFor—
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForABSTAIN or AGAINST — 9 of 17 Brighthouse fundsAgainstNot approved, 33.7% support
Oracle Corporation2025-11-18Elect Awo AbloForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Charles W. MoormanForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Clayton M. MagouyrkForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect George H. ConradesForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Jeffrey O. HenleyForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Jeffrey S. BergForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Lawrence J. EllisonForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Michael D. SiciliaForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Michael J. BoskinForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Naomi O. SeligmanForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Rona FairheadForWITHHOLD — 5 of 8 Brighthouse fundsFor—
Oracle Corporation2025-11-18Elect Safra A. CatzForWITHHOLD — 5 of 8 Brighthouse fundsFor—
PepsiCo, Inc.2026-05-06Ratification of appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2026.ForABSTAIN or AGAINST — 5 of 8 Brighthouse fundsFor—
Danaher Corporation2026-05-05To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane SandersForAGAINST or ABSTAIN — 6 of 10 Brighthouse fundsForElected, 73.8% support
The Boeing Company2026-04-17Election of Directors: Mortimer Tim J. BuckleyForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Andrew K. SilvernailForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Emmanuel P. MacedaForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Giovanni Caforio, M.D.ForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Kevin A. LoboForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Lisa M. Skeete TatumForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Mary K. BrainerdForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Rachel M. RuggeriForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Rajeev SuriForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Ronda E. StrykerForABSTAIN — 5 of 8 Brighthouse fundsFor—
Stryker Corporation2026-05-06Election of Directors: Sherilyn S. McCoyForABSTAIN — 5 of 8 Brighthouse fundsFor—
HCA Healthcare, Inc.2026-04-23Election of Directors: Nancy-Ann DeParleForABSTAIN or AGAINST — 6 of 10 Brighthouse fundsForPassed (calculated), 88.6% support
HCA Healthcare, Inc.2026-04-23To ratify the appointment of Ernst & Young LLP as our Independent registered public accounting firm for the year ending December 31, 2026.ForABSTAIN — 5 of 8 Brighthouse fundsFor—
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships.ForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsFor—
KKR & Co. Inc.2026-05-21Other amendments to the Existing Charter to modernize and streamline the Existing Charter.ForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsFor—
KKR & Co. Inc.2026-05-21The adjournment of the Special Meeting, from time to time, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of any of the amendments to the Existing Charter.ForAGAINST or ABSTAIN — 5 of 8 Brighthouse fundsFor—
Synopsys, Inc.2026-04-16To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2026.ForABSTAIN or AGAINST — 6 of 10 Brighthouse fundsForApproved, 92.5% support
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Arvind KrishnaForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Christopher W. GradyForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: David P. AbneyForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Gary RougheadForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Kathy J. WardenForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Kimberly A. RossForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Mark A. Welsh IIIForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Mary A. WinstonForABSTAIN — 5 of 8 Brighthouse fundsFor—
Northrop Grumman Corporation2026-05-20Election of Directors Nominees: Thomas M. SchoeweForABSTAIN — 5 of 8 Brighthouse fundsFor—
Datadog, Inc.2026-06-15To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Shardul ShahForWITHHOLD — 6 of 10 Brighthouse fundsForElected, 83.8% support
Flex Ltd.2025-08-06To approve a general authorization for the directors of Flex to allot and issue ordinary shares.ForAGAINST — 6 of 10 Brighthouse fundsForPassed (calculated), 95.7% support
Flex Ltd.2025-08-06To approve the re-appointment of Deloitte & Touche LLP as our independent auditors for the 2026 fiscal year and to authorize the Board of Directors, upon the recommendation of the Audit Committee, to fix their remuneration.ForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 95.5% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Charles K. Stevens, IIIForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 99.4% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Erin L. McSweeneyForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 98.6% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: John D. Harris IIForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 99.5% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Lay Koon TanForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 95.1% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Maryrose SylvesterForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 99.4% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Michael E. HurlstonForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 85.8% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Patrick J. WardForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 99.8% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: Revathi AdvaithiForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 99.0% support
Flex Ltd.2025-08-06To approve the re-election of each of the following directors, who will retire pursuant to Article 94 of our Constitution, to the Board of Directors: William D. WatkinsForABSTAIN — 6 of 10 Brighthouse fundsForPassed (calculated), 93.7% support
BridgeBio Pharma, Inc.2026-06-22To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.ForABSTAIN or AGAINST — 5 of 8 Brighthouse fundsForApproved, 82.9% support
CG Oncology, Inc.2026-06-04To elect the Board's two nominees for Class II director named as nominees to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Victor Tong, Jr.ForWITHHOLD — 5 of 8 Brighthouse fundsForElected, 92.3% support
Walmart Inc.2026-06-04Election of Directors: Randall L. StephensonForABSTAIN or AGAINST — 8 of 15 Brighthouse fundsForElected, 96.2% support
AbbVie Inc.2026-05-08Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026.ForABSTAIN — 4 of 6 Brighthouse fundsFor—
The Goldman Sachs Group, Inc.2026-04-29Shareholder Shareholder Proposal Regarding Lobbying DisclosureForABSTAIN — 8 of 15 Brighthouse fundsAgainstNot approved, 38.0% support
The Goldman Sachs Group, Inc.2026-04-29Shareholder Shareholder Proposal Regarding Special Shareholder Meeting ThresholdsForABSTAIN or AGAINST — 8 of 15 Brighthouse fundsAgainstFailed (calculated), 36.9% support
Eaton Corporation plc2026-04-22Election of Directors: Andre SchultenForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Darryl L. WilsonForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Gerald JohnsonForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Karenann TerrellForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Lori J. RyerkerkForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Paulo RuizForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Robert V. PragadaForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Sandra PianaltoForABSTAIN — 4 of 6 Brighthouse fundsFor—
Eaton Corporation plc2026-04-22Election of Directors: Silvio NapoliForABSTAIN — 4 of 6 Brighthouse fundsFor—
Starbucks Corporation2026-03-25Approve, on a non-binding, advisory basis, the compensation of our named executive officers (say-on-pay)ForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsFor—
Marvell Technology, Inc.2026-06-25Shareholder To consider and act on one stockholder proposal, entitled "Independent Board Chairman", if properly presented at the Annual Meeting.AgainstFOR — 3 of 4 Brighthouse fundsForNot approved, 36.9% support
Snowflake Inc.2026-06-29Election of Class III Directors for term expiring in 2029: Teresa BriggsWithholdFOR — 3 of 4 Brighthouse fundsAgainst—
Intuit Inc.2026-01-22Ratification of the selection of Ernst & Young LLP as Intuit's independent registered public accounting firm for the fiscal year ending July 31, 2026ForABSTAIN or AGAINST — 8 of 15 Brighthouse fundsForPassed (calculated), 92.0% support
Cencora, Inc.2026-03-05Election of Directors: D. Mark DurcanForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Dennis M. NallyForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Ellen G. CooperForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Frank K. ClyburnForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Lauren M. TylerForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Lon R. GreenbergForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Lorence H. Kim, M.D.ForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Lori J. RyerkerkForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Redonda G. Miller, M.D.ForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Robert P. MauchForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Election of Directors: Werner BaumannForABSTAIN — 4 of 6 Brighthouse fundsFor—
Cencora, Inc.2026-03-05Ratification of the appointment of Ernst & Young LLP as Cencora, Inc.'s independent registered public accounting firm for fiscal 2026.ForABSTAIN — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Amanda M. BrockForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Ann G. FoxForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Brent J. SmolikForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Clay M. GasparForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Jacinto J. HernandezForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Jeffrey E. ShellebargerForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Karl F. KurzForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Marcus A. WattsForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Thomas E. JordenForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Devon Energy Corporation2026-06-30Elect Valerie M. WilliamsForWITHHOLD — 4 of 6 Brighthouse fundsFor—
Waters Corporation2026-05-21To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsFor—
NetApp, Inc.2025-09-10To ratify the selection of Deloitte & Touche LLP as NetApp's independent registered public accounting firm for the fiscal year ending April 24, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsFor—
EQT Corporation2026-04-14Election of Directors: Vicky A. BaileyForABSTAIN or AGAINST — 3 of 4 Brighthouse fundsFor—
Axon Enterprise, Inc.2026-05-28Election of Directors: Adriane BrownForABSTAIN or AGAINST — 4 of 6 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Allison M. WingForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Cara K. HeidenForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Darren M. RebelezForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: David K. LenhardtForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Donald E. FriesonForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Gregory A. TrojanForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Judy A. SchmelingForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Larree M. RendaForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Maria Castanon MoatsForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Michael SpanosForABSTAIN — 3 of 4 Brighthouse fundsFor—
Casey's General Stores, Inc.2025-09-03Election of Director to serve until the next Annual Shareholders Meeting and until their successors are elected and qualified: Sri DonthiForABSTAIN — 3 of 4 Brighthouse fundsFor—
BridgeBio Pharma, Inc.2026-06-22Elect Frank McCormickForWITHHOLD — 3 of 4 Brighthouse fundsFor—
BridgeBio Pharma, Inc.2026-06-22Elect Hannah A. ValantineForWITHHOLD — 3 of 4 Brighthouse fundsFor—
BridgeBio Pharma, Inc.2026-06-22Elect James C. MomtazeeForWITHHOLD — 3 of 4 Brighthouse fundsFor—
Kymera Therapeutics, Inc.2026-06-24Elect Bruce BoothForWITHHOLD — 3 of 4 Brighthouse fundsFor—
Kymera Therapeutics, Inc.2026-06-24Elect Elena RidloffForWITHHOLD — 3 of 4 Brighthouse fundsFor—
Kymera Therapeutics, Inc.2026-06-24Elect John M. MaraganoreForWITHHOLD — 3 of 4 Brighthouse fundsFor—
Kymera Therapeutics, Inc.2026-06-24Elect Nello MainolfiForWITHHOLD — 3 of 4 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Non-binding advisory resolution regarding the compensation of our Named Executive Officers (Say on Pay)ForABSTAIN — 3 of 4 Brighthouse fundsFor—
KBR, Inc.2026-05-14Election of Directors: Sir John A. Manzoni KCBAgainstFOR — 4 of 6 Brighthouse fundsAgainstElected, 96.8% support
NewAmsterdam Pharma Company N.V.2026-06-02Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2025.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 100.0% support
NewAmsterdam Pharma Company N.V.2026-06-02Approval of the NewAmsterdam Pharma Company N.V. 2026 Employee Stock Purchase Plan.ForAGAINST — 3 of 4 Brighthouse fundsFor—
NewAmsterdam Pharma Company N.V.2026-06-02Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2025.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 98.7% support
NewAmsterdam Pharma Company N.V.2026-06-02Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2026.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 100.0% support
NewAmsterdam Pharma Company N.V.2026-06-02Non-binding, advisory vote to approve the 2025 compensation of named executive officers.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 94.3% support
NewAmsterdam Pharma Company N.V.2026-06-02Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 by the audit committee of the Company's Board of Directors.ForABSTAIN — 3 of 4 Brighthouse fundsForApproved, 100.0% support
NewAmsterdam Pharma Company N.V.2026-06-02Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. Janneke van der Kamp until the 2030 annual general meetingForABSTAIN — 3 of 4 Brighthouse fundsFor—
NewAmsterdam Pharma Company N.V.2026-06-02Reappointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name. John W. Smither until the 2030 annual general meetingForABSTAIN — 3 of 4 Brighthouse fundsFor—
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: David P. Schenkein, M.D.ForABSTAIN — 7 of 13 Brighthouse fundsForElected, 96.0% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Huda Y. Zoghbi, M.D.ForABSTAIN — 7 of 13 Brighthouse fundsForElected, 97.4% support
Broadcom Inc.2026-04-20Ratification of the appointment of Pricewaterhouse-Coopers LLP as the independent registered public accounting firm of Broadcom for the fiscal year ending November 1, 2026.ForABSTAIN — 6 of 11 Brighthouse fundsFor—
Berkshire Hathaway Inc.2026-05-02Non-binding resolution to determine the frequency (whether annual, biennial or triennial) with which shareholders of the company shall be entitled to have an advisory vote on executive compensation.ForABSTAIN — 6 of 11 Brighthouse fundsAgainst—
Autodesk, Inc.2026-06-17Election of Directors: John T. CahillAgainstFOR — 6 of 11 Brighthouse fundsAgainstPassed (calculated), 94.7% support
Newmont Corporation2026-05-12Election of Directors: Jose Manuel MaderoForABSTAIN — 5 of 9 Brighthouse fundsForPassed (calculated), 99.7% support
Newmont Corporation2026-05-12Election of Directors: Rene MedoriForABSTAIN — 5 of 9 Brighthouse fundsForPassed (calculated), 99.7% support
CVS Health Corporation2026-05-14Shareholder Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.AgainstFOR — 5 of 9 Brighthouse fundsFor—
American International Group, Inc.2026-05-13Advisory vote to approve named executive officer compensation.AgainstFOR — 5 of 9 Brighthouse fundsAgainstPassed (calculated), 77.5% support
Lowe's Companies, Inc.2026-05-29Elect Bertram L. ScottForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Brian C. RogersForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Colleen TaylorForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Laurie Z. DouglasForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Lawrence SimkinsForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Marvin R. EllisonForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Mary Elizabeth WestForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Navdeep GuptaForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Raul AlvarezForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Richard W. DreilingForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Sandra B. CochranForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Lowe's Companies, Inc.2026-05-29Elect Scott H. BaxterForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Starbucks Corporation2026-03-25Election of Directors: Jorgen Vig KnudstorpForABSTAIN or AGAINST — 3 of 5 Brighthouse fundsForElected, 94.7% support
Nucor Corporation2026-05-14Approval, on an advisory basis, of Nucor's named executive officer compensation in 2025.ForABSTAIN — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Leon J. TopalianForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Michael W. LamachForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Nadja Y. WestForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Nicholas C. GangestadForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Norma B. ClaytonForWITHHOLD — 3 of 5 Brighthouse fundsFor—
Nucor Corporation2026-05-14Elect Patrick J. DempseyForWITHHOLD — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Barbara B. HulitForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Brice A. HillForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Dame Alison J. CarnwathForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Dr. Dietmar A. ScheiterForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Ganesh RamaswamyForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: John M. PigottForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Kirk S. HachigianForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Luiz A. S. PrettiForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Mark C. PigottForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: Pierre R. BreberForABSTAIN — 3 of 5 Brighthouse fundsFor—
PACCAR Inc2026-04-28Election of Directors to serve for one-year term: R. Preston FeightForABSTAIN — 3 of 5 Brighthouse fundsFor—
Coherent Corp.2025-11-13Election of Director for a three-year term to expire at the annual meeting of shareholders in 2028: David L. MotleyForABSTAIN — 3 of 5 Brighthouse fundsFor—
Coherent Corp.2025-11-13Election of Director for a three-year term to expire at the annual meeting of shareholders in 2028: Enrico DiGirolamoForABSTAIN — 3 of 5 Brighthouse fundsFor—
Coherent Corp.2025-11-13Election of Director for a three-year term to expire at the annual meeting of shareholders in 2028: Michelle SterlingForABSTAIN — 3 of 5 Brighthouse fundsFor—
Coherent Corp.2025-11-13Election of Director for a three-year term to expire at the annual meeting of shareholders in 2028: Shaker SadasivamForABSTAIN — 3 of 5 Brighthouse fundsFor—
Atmos Energy Corporation2026-02-04Proposal to amend the Articles of Incorporation (Articles) to increase the number of authorized shares of common stockForAGAINST — 3 of 5 Brighthouse fundsFor—
US Foods Holding Corp.2026-05-14Election of Directors: Carl A. PforzheimerForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Alpna SethForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Amy HerrForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: John L. HigginsForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Joseph D. KeeganForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Judith KlimovskyForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Julie L. BushmanForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Kim KeldermanForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Robert V. BaumgartnerForABSTAIN — 3 of 5 Brighthouse fundsFor—
Bio-Techne Corporation2025-10-30Election of Directors: Rupert VesseyForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Caroline LevyForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Cheryl MillerForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Damon DeSantisForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Fletcher PrevinForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Hal KravitzForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John FieldlyForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: John ShortForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Joyce RussellForABSTAIN — 3 of 5 Brighthouse fundsFor—
Celsius Holdings, Inc.2026-05-28Election of Director to serve until the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Nick CastaldoForABSTAIN — 3 of 5 Brighthouse fundsFor—
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeForWITHHOLD — 3 of 5 Brighthouse fundsForPassed (calculated), 80.6% support
Johnson Controls International plc2026-03-04To ratify the appointment of PricewaterhouseCoopers LLP as the independent auditors of the CompanyForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsFor—
Sempra2026-05-12Election of Directors: Michael N. MearsForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsFor—
Teva Pharmaceutical Industries Ltd.2026-05-28To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2027 Annual Meeting of ShareholdersForABSTAIN or AGAINST — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal. Brian S. PosnerForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal. Eileen MalleschForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal. Francis EbongForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Alan TiernanForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Brian ChenForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Chris HoveyForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Christine ToddForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Crystal DoughtyForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. David J. MulhollandForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Jerome HalganForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Maamoun RajehForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Matthew DragonettiForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. Seamus FearonForABSTAIN — 2 of 3 Brighthouse fundsFor—
Arch Capital Group Ltd.2026-05-05To elect the nominees listed as Designated Company Directors so that they may be elected directors of certain of our non-U.S. subsidiaries. William SoaresForABSTAIN — 2 of 3 Brighthouse fundsFor—
F5, Inc.2026-03-12To elect eight (8) directors nominated by the Board to hold office until the annual meeting of shareholders for fiscal year 2026: ulie M. GonzalezForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Barbara J. BeckForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Danielle M. BrownForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: David V. SingerForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: George L. HolmForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Jeffrey M. OverlyForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Kimberly S. GrantForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Laura FlanaganForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Manuel A. FernandezForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Matthew C. FlaniganForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Randall N. SprattForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Scott D. FergusonForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: Warren M. ThompsonForABSTAIN — 2 of 3 Brighthouse fundsFor—
Performance Food Group Company2025-11-19To elect director nominees: William F. Dawson, Jr.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Albert ChaForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Jan Moller MikkelsenForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Jean-Jacques BienaimeForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Lars HoltugForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Lisa Jane MorrisonForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect Siham ImaniForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Elect William FaireyForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Election of Chairman of the MeetingForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Election of State-authorized Public AuditorForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Presentation of Audited Annual Report with Auditor's Statement for Approval and Discharge of the Board of Directors and ManagementForABSTAIN — 2 of 3 Brighthouse fundsFor—
Ascendis Pharma A/S2026-03-23Resolution on Application of Profits or Covering of Losses as per the Adopted Annual ReportForABSTAIN — 2 of 3 Brighthouse fundsFor—
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Class I Nominees (each for a term of three years): Alejandro Quiroz CentenoForABSTAIN — 2 of 3 Brighthouse fundsFor—
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Class I Nominees (each for a term of three years): Carl R. ChristensonForABSTAIN — 2 of 3 Brighthouse fundsFor—
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Class I Nominees (each for a term of three years): Katrina L. HelmkampForABSTAIN — 2 of 3 Brighthouse fundsFor—
IDEX Corporation2026-05-06Election of four directors named in the proxy statement as follows: Class I Nominees (each for a term of three years): Mark A. BeckForABSTAIN — 2 of 3 Brighthouse fundsFor—
Clean Harbors, Inc.2026-05-20Elect Alison A. QuirkForWITHHOLD — 2 of 3 Brighthouse fundsFor—
Clean Harbors, Inc.2026-05-20Elect Edward G. GalanteForWITHHOLD — 2 of 3 Brighthouse fundsFor—
Clean Harbors, Inc.2026-05-20Elect John R. WelchForWITHHOLD — 2 of 3 Brighthouse fundsFor—
Clean Harbors, Inc.2026-05-20Elect Shelley Stewart, Jr.ForWITHHOLD — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Curtis W. StoeltingForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Gerben W. BakkerForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Jan A. BertschForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Louis V. PinkhamForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Michael F. HiltonForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Michael P. DossForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Rakesh SachdevForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Rashida A. HodgeForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Robin A. Walker-LeeForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Stephen M. BurtForABSTAIN — 2 of 3 Brighthouse fundsFor—
Regal Rexnord Corporation2026-04-28Election of Directors whose terms would expire in 2027: Theodore D. CrandallForABSTAIN — 2 of 3 Brighthouse fundsFor—
e.l.f. Beauty, Inc.2025-08-21Elect Chip BerghForWITHHOLD — 2 of 3 Brighthouse fundsFor—
e.l.f. Beauty, Inc.2025-08-21Elect Lori KeithForWITHHOLD — 2 of 3 Brighthouse fundsFor—
e.l.f. Beauty, Inc.2025-08-21Elect Tarang AminForWITHHOLD — 2 of 3 Brighthouse fundsFor—
The Vita Coco Company, Inc.2026-06-03Elect Kenneth SadowskyForWITHHOLD — 2 of 3 Brighthouse fundsFor—
The Vita Coco Company, Inc.2026-06-03Elect Michael KirbanForWITHHOLD — 2 of 3 Brighthouse fundsFor—
The Vita Coco Company, Inc.2026-06-03Elect Shelley G. BroaderForWITHHOLD — 2 of 3 Brighthouse fundsFor—
The Vita Coco Company, Inc.2026-06-03Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Structure Therapeutics Inc.2026-06-17Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Daniel G. WelchForABSTAIN — 2 of 3 Brighthouse fundsFor—
Structure Therapeutics Inc.2026-06-17Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Raymond Stevens, Ph.D.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Structure Therapeutics Inc.2026-06-17Election of the nominees for Class III director named below to hold office until the 2029 annual general meeting of shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal. Ted W. Love, M.D.ForABSTAIN — 2 of 3 Brighthouse fundsFor—
Structure Therapeutics Inc.2026-06-17To ratify the appointment by the Audit Committee of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.ForABSTAIN — 2 of 3 Brighthouse fundsFor—

Download all 481 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 88.7% of this fund’s 2,157 such votes could be given a sector; the other 243 (11.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care407184.4%
Consumer Discretionary323309.3%
Technology3134313.7%
Industrials282103.5%
Finance218125.5%
Utilities10954.6%
Consumer Staples10498.7%
Energy5423.7%
Basic Materials3612.8%
Telecommunications3100.0%
Miscellaneous2600.0%
Real Estate1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,4630
Audit-related1790
Say-on-Pay1601
Corporate Governance8823
Compensation765
Capital Structure752
Shareholder Rights and Defenses4025
Other Social Issues3630
Environment or Climate2020
Human Rights or Human Capital/workforce1717

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Apple Inc.February 24, 2026$201M121
NVIDIA CorporationJune 24, 2026$181M164
Microsoft CorporationDecember 5, 2025$175M216
Amazon.com, Inc.May 20, 2026$137M174
Alphabet Inc.June 5, 2026$101M2310
Broadcom Inc.April 20, 2026$74M100
Advanced Micro Devices, Inc.May 13, 2026$72M121
Meta Platforms, Inc.May 27, 2026$69M2310

Notable votes against management

MeetingCompanyProposalFundMgmt
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.Shareholder Proposal Requesting A Report On Charitable Partnerships Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.Shareholder Proposal Requesting Additional Reporting On Impact Of Data Centers On Climate Commitments Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
May 13, 2026Advanced Micro Devices, Inc.Stockholder proposal requesting changes to the stockholder right to call a special meeting. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on AI data usage oversight. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst

Search this fund’s votes by company

2,163 ballot items at 174 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Brighthouse/Wellington Large Cap Research Portfolio voted at 174 shareholder meetings of 169 companies, on 2,163 ballot items in all. Where management made a recommendation, the fund followed it on 93.7% of the items and voted against it 131 times. Its most frequent area of disagreement was other social issues (30 of its votes against management). It voted FOR 25.8% of the 132 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Brighthouse's funds as a whole (97.0% against 76.3%). It voted differently from most Brighthouse funds on 481 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.